Heart and Vascular Disease: Translation of Biological Advances to the Clinic

Event Details
Contact

Alice Li

Summaries

Summary Sentence: Arshed Quyyumi, MD, FRCP - Department of Cardiology, Emory University School of Medicine

Full Summary: BBUGS Conversations with Clinicians Seminar"Heart and Vascular Disease: Translation of Biological Advances to the Clinic"Arshed Quyyumi, MD, FRCP - Department of Cardiology, Emory University School of Medicine

Dr. Quyyumi will be discussing his Amorcyte Myocardial Repair study, a Phase I clinical trial in which CD34+ bone-marrow-derived autologous cells are injected into the heart to treat acute myocardial infarctions. Heart attacks, which affect more than 1 million Americans a year, can cause congenital heart failure, where the heart muscle is damaged and can no longer effectively pump blood to the rest of the body. Endothelial protenitor cells, or EPCs, are cells that have been shown to aid in new blood vessel formation after injury. This study looks into the effect of treating damaged heart tissue with EPCs, with the hopes that these cells facilitate development of new blood vessels that may aid in repair of the heart muscle.

Additional Information

In Campus Calendar
No
Groups

Parker H. Petit Institute for Bioengineering and Bioscience (IBB)

Invited Audience
No audiences were selected.
Categories
Seminar/Lecture/Colloquium
Keywords
BBUGS
Status
  • Created By: Colly Mitchell
  • Workflow Status: Published
  • Created On: Apr 19, 2011 - 4:43am
  • Last Updated: Oct 7, 2016 - 9:54pm